1. Aman, M.G.
(1984), “Drugs and learning in mentally retarded persons”, in
Burrows, G.D.
and
Werry, J.S.
(Eds), Advances in Human Psychopharmacology, JAI Press, Greenwich, CT, pp. 121-63.
2. Bhaumik, S.
and
Michael, D.M.
(2004), “Pharmacotherapy and pharmaco-vigilance in intellectual disability”, Intellectual Disability Psychiatry, Vol. 6, pp. 9-10.
3. Borthwick-Duffy, S.A.
(1994), “Prevalence of destructive behaviours”, in
Thompson, T.
and
Gray, D.B.
(Eds), Destructive Behaviour in Developmental Disabilities: Diagnosis and Treatment, Sage, Thousand Oaks, CA, pp. 3-23.
4. Branford, D.
(1997), “A follow-up study of prescribing for people with intellectual disabilities previously in National Health Service care in Leicestershire, England”, Journal of Intellectual Disability Research, Vol. 41 No. 4, pp. 339-45.
5. Brylewski, J.
and
Duggan, L.
(1999), “Antipsychotic medication for challenging behaviour in people with intellectual disability: a systematic review of randomised controlled trials”, Journal of Intellectual Disability Research, Vol. 43 No. 5, pp. 360-71.